The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy
for the treatment of ailments affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated decrease in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the security of testosterone. The study included approximately 800 older men with low testosterone and symptoms associated with this condition, such http://tinyurl.com/hvm4td7
as physical and sexual dysfunction. Since the heart health of the men was monitored, the research is expected to shed more light on the safety of testosterone therapy.
Studies have shown that testosterone deficiency is related to a number of important health issues such as obesity, diabetes, metabolic syndrome, and bone fractures Men who meet medical criteria for treatment should receive therapy. In reality, your testosterone levels have likely been slowly decreasing for quite some time, a decline that usually begins around age 30.
And many girls have a knee jerk feeling that any hormone treatment can raise their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only does not raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser believes this will likely stay the status quo for a little while, given the prohibitive cost of running the long-term safety studies needed to gain fuller FDA approval.